Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease

Basit Öğe Kaydı
dc.contributor.authorÖzkurt, Sultan
dc.contributor.authorDoğan, İbrahim
dc.contributor.authorÖzcan, Oğuzhan
dc.contributor.authorFidan, Nurdan
dc.contributor.authorBozacı, İlter
dc.contributor.authorYılmaz, Behice
dc.contributor.authorBilgin, Muzaffer
dc.date.accessioned2019-05-10T09:40:08Z
dc.date.available2019-05-10T09:40:08Z
dc.date.issued2019
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractPurpose: The decrease in kidney functions in autosomal dominant polycystic kidney disease (ADPKD) is strongly correlated with the severity and growth of kidney cysts. Total kidney volume (TKV) was shown to be an early marker of the severity of the disease and a predictor of reduction in kidney functions. New treatment approaches for ADPKD have led to a need for easily applicable strong biomarkers predicting progression of the disease. The profibrotic mediator of galectin-3 (Gal-3) is linked to development of renal fibrosis. Methods: The study included 74 patients with ADPKD diagnosis and 40 healthy controls. The TKV of patients was calculated using the manual tracing method on MR images. The serum Gal-3 levels of patient and healthy control groups were measured with the ELISA method. The correlations between serum Gal-3 value with TKV and kidney function were assessed in patients. Results: As the stage of chronic kidney disease (CKD) increased, serum Gal-3 and TKV values increased (p < 0.001, p = 0.049, respectively). Correlation analysis found a negative relationship between serum Gal-3 levels and eGFR (r: ? 0.515, p < 0.001); however, there was no relationship between serum Gal-3 and TKV (r = 0.112, p = 0.344). Linear regression analysis showed the major parameter affecting Gal-3 was eGFR (p = 0.016). Conclusions: In our study, we showed that renal impairment is an important determinant of Gal-3, and there is no correlation of Gal-3 and TKV in ADPKD. As a result, there is an urgent clinical need for new biomarkers to identify individuals with the chance of treatment in the early stage among ADPKD patients. © 2019, Springer Nature B.V.
dc.identifier.citationÖzkurt, S., Doğan, İ., Özcan, O., Fidan, N., Bozacı, İ., Yılmaz, B., Bilgin, M. (2019). Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease. International Urology and Nephrology, 51(7), 1191-1197.
dc.identifier.doi10.1007/s11255-019-02156-8
dc.identifier.endpage1197
dc.identifier.issn0301-1623
dc.identifier.issue7
dc.identifier.scopusqualityQ2
dc.identifier.startpage1191
dc.identifier.urihttps://doi.org/10.1007/s11255-019-02156-8
dc.identifier.urihttps://hdl.handle.net/11491/848
dc.identifier.volume51
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer Netherlands
dc.relation.ispartofInternational Urology and Nephrology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAutosomal Dominant Polycystic Kidney Diseaseen_US
dc.subjectFibrosisen_US
dc.subjectGalectin 3en_US
dc.subjectTotal Kidney Volumeen_US
dc.titleCorrelation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease
dc.typeArticle

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu